의료 기술
스위스 회사 의료 기술
의료 기기, 진단 장비 및 의료 서비스 플랫폼 개발은 헬스테크 산업을 정의합니다. 규제 승인 기간과 변화하는 메디케어 환급 모델은 이러한 주식에 지속적으로 유동성을 공급합니다. 현재 Novartis AG 거래량에서 우위를 점하고 있으며, Inovio Pharmaceuticals, Inc. 24시간 동안 가장 강력한 성장세를 보이고 있습니다. 아래 표는 핵심 기술 및 기본 데이터를 정리합니다.
심볼 | 시가총액 | 가격 | 체인지 % | 볼륨 | 상대 볼륨 | P/E | EPS 희석 순마진 | EPS 희석 성장 TTM YoY | 배당 수익 % 순마진 | 애널리스트 평점 |
|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly and Company | 1.09 T CHF | 1,180 CHF | +23.56% | 1 | 0.31 | 46.38 | 25.44 CHF | +57.99% | 0.47% | 강력 매수 |
| LLYEli Lilly and Company | 1.09 T CHF | 1,104.870 CHF | −5.56% | 6 | 0.13 | 43.42 | 25.44 CHF | +57.99% | 0.47% | 강력 매수 |
 JNJJohnson & Johnson | 543.72 B CHF | 227.679 CHF | +3.11% | 12 | 0.87 | 41.32 | 5.51 CHF | −33.23% | 1.91% | 매수 |
| JNJ.USDJohnson & Johnson | 543.72 B CHF | 261.25 USD | 0.00% | 177 | 0.35 | 39.63 | 5.51 CHF | −36.38% | 1.91% | 매수 |
 ABBVAbbVie, Inc. | 425.98 B CHF | 236.65 CHF | +1.24% | 20 | 0.30 | 48.72 | 4.86 CHF | +360.13% | 2.35% | 매수 |
| 4ABAbbVie, Inc. | 425.98 B CHF | 240.889 CHF | +13.10% | 1.35 K | 9.21 | 49.60 | 4.86 CHF | +360.13% | 2.35% | 매수 |
 RORoche Holding Ltd | 315.59 B CHF | 400.0 CHF | +0.25% | 64.81 K | 2.40 | 26.10 | 15.33 CHF | +30.49% | 2.69% | 매수 |
| RHORoche Holding Ltd | 315.59 B CHF | 405.099 CHF | −0.76% | 15 | 0.73 | 26.43 | 15.33 CHF | +30.49% | 2.69% | 매수 |
| ROPRoche Holding Ltd | 315.59 B CHF | 386.324 CHF | −1.65% | 344 | 0.41 | 25.21 | 15.33 CHF | +30.49% | 2.48% | 매수 |
| ROPRoche Holding Ltd | 315.59 B CHF | 390.3 CHF | −0.36% | 1.44 M | 1.30 | 25.47 | 15.33 CHF | +30.49% | 2.48% | 매수 |
 6MKMerck & Co., Inc. | 303.22 B CHF | 123.142 CHF | +4.32% | 16 | 0.65 | 150.44 | 0.82 CHF | −86.41% | 2.26% | 매수 |
| MRK.USDMerck & Co., Inc. | 303.22 B CHF | 151.22 USD | 0.00% | 1.24 K | 0.89 | 154.43 | 0.82 CHF | −87.05% | 2.26% | 매수 |
 NOVNNovartis AG | 245.77 B CHF | 133.08 CHF | −0.78% | 4.01 M | 1.00 | 32.07 | 4.15 CHF | −33.04% | 2.76% | 중립 |
| NOTNovartis AG | 245.77 B CHF | 132.760 CHF | −1.75% | 127 | 0.24 | 32.00 | 4.15 CHF | −33.04% | 2.76% | 중립 |
| NOVNEENovartis AG TEMP | 245.77 B CHF | 132.56 CHF | −1.88% | 130 K | 0.45 | 31.95 | 4.15 CHF | −33.04% | 2.76% | 등급 없음 |
 ZEGAstraZeneca PLC | 239.39 B CHF | 155.416 CHF | +1.57% | 211 | 9.91 | 26.62 | 5.84 CHF | +18.22% | 1.70% | 매수 |
 TN8Thermo Fisher Scientific Inc. | 213.87 B CHF | 546.250 CHF | −2.06% | 2 | 0.65 | 34.48 | 15.84 CHF | +14.93% | 0.26% | 매수 |
 AMGAmgen Inc. | 211.44 B CHF | 388.337 CHF | +1.70% | 9 | 0.76 | 26.94 | 14.41 CHF | +39.89% | 2.08% | 중립 |
 GISGilead Sciences, Inc. | 176.9 B CHF | 134.099 CHF | −5.57% | 20 | 0.15 | — | −2.63 CHF | −151.18% | 1.86% | 매수 |
 ABLAbbott Laboratories | 163.38 B CHF | 94.775 CHF | +6.44% | 631 | 30.05 | 41.86 | 2.26 CHF | −64.34% | 2.18% | 매수 |
 NVONovo Nordisk A/S Sponsored ADR Class BDR | 154.8 B CHF | 33.873 CHF | +4.89% | 30 | 0.03 | 10.21 | 3.32 CHF | +21.39% | 2.92% | 중립 |
| NOVNovo Nordisk A/S Class B | 154.8 B CHF | 33.068 CHF | +0.66% | 248 | 0.14 | 10.27 | 3.22 CHF | +10.70% | 4.10% | 중립 |
 PFEPfizer Inc. | 143.45 B CHF | 23.577 CHF | −5.69% | 4.31 K | 10.28 | 40.34 | 0.58 CHF | −57.23% | 5.59% | 중립 |
 IUI1Intuitive Surgical, Inc. | 136.6 B CHF | 375.728 CHF | −4.11% | 25 | 1.59 | 54.38 | 6.91 CHF | +14.81% | 0.00% | 매수 |
 DAPDanaher Corporation | 135.1 B CHF | 187.464 CHF | −1.94% | 1.65 K | 44.59 | 36.72 | 5.11 CHF | +31.91% | 0.65% | 매수 |
 VX1Vertex Pharmaceuticals Incorporated | 113.78 B CHF | 439.008 CHF | −2.56% | 10 | 0.30 | 33.78 | 12.99 CHF | +14.99% | 0.00% | 매수 |
 2M6Medtronic Plc | 109.74 B CHF | 85.457 CHF | −0.24% | 4 | 0.15 | 26.04 | 3.28 CHF | +11.14% | 2.72% | 매수 |
 BRMBristol-Myers Squibb Company | 107.25 B CHF | 51.175 CHF | +1.34% | 10 | 0.03 | 13.57 | 3.77 CHF | +59.93% | 3.93% | 매수 |
 SYKStryker Corporation | 105.69 B CHF | 257.002 CHF | +2.09% | 7 | 0.13 | 32.75 | 7.85 CHF | +29.36% | 1.04% | 매수 |
 SANSanofi SA | 92.58 B CHF | 67.98 CHF | 0.00% | 450 | 0.13 | 22.12 | 3.07 CHF | −36.38% | 4.90% | 매수 |
| SNWSanofi SA | 92.58 B CHF | 77.442 CHF | +6.14% | 495 | 2.82 | 25.20 | 3.07 CHF | −36.38% | 4.90% | 매수 |
 MRNAModerna, Inc. | 84.32 B CHF | 161.56 CHF | −20.41% | 8 | — | — | −6.45 CHF | −8.21% | 0.00% | 중립 |
| 0QFModerna, Inc. | 84.32 B CHF | 214.368 CHF | +8.91% | 2.19 K | 10.49 | — | −6.45 CHF | −8.21% | 0.00% | 중립 |
| MRNA.USDModerna, Inc. | 84.32 B CHF | 226.80 USD | 0.00% | 1.93 K | 1.55 | — | −6.45 CHF | −6.20% | 0.00% | 중립 |
 GS71GSK plc | 83.39 B CHF | 20.522 CHF | +1.52% | 3 | 0.04 | 17.34 | 1.18 CHF | −17.14% | 3.60% | 중립 |
 EL1EssilorLuxottica SA | 80.36 B CHF | 179.30 CHF | 0.00% | 1.73 K | 1.57 | 36.29 | 4.94 CHF | +2.56% | 2.12% | 매수 |
| ESLEssilorLuxottica SA | 80.36 B CHF | 175.776 CHF | +9.63% | 100 | 1.13 | 35.58 | 4.94 CHF | +2.56% | 2.12% | 매수 |
 MRKMerck KGaA | 60.03 B CHF | 138.411 CHF | +6.22% | 200 | 1.68 | 27.50 | 5.03 CHF | −18.23% | 1.46% | 매수 |
 BSXBoston Scientific Corporation | 54.29 B CHF | 37.640 CHF | −0.39% | 500 | 2.74 | 19.06 | 1.97 CHF | +32.59% | 0.00% | 매수 |
 CSJCSL Limited | 54.2 B CHF | 113.768 CHF | −1.02% | 386 | 1.17 | — | −4.25 CHF | −186.00% | 2.05% | 매수 |
 UNCUCB S.A. | 49.28 B CHF | 254.278 CHF | +5.56% | 30 | 1.03 | 24.36 | 10.44 CHF | +62.96% | 0.36% | 매수 |
 BAYNBayer AG | 48.9 B CHF | 43.46 CHF | 0.00% | 600 | 0.69 | — | −1.63 CHF | +49.77% | 0.20% | 매수 |
| BAYNBayer AG | 48.9 B CHF | 50.052 CHF | −2.26% | 480 | 0.51 | — | −1.63 CHF | +49.77% | 0.20% | 매수 |
 SHLSiemens Healthineers AG | 45.93 B CHF | 41.12 CHF | +11.14% | 25 | 0.02 | 22.56 | 1.82 CHF | +1.10% | 2.23% | 매수 |
| SHLSiemens Healthineers AG | 45.93 B CHF | 40.107 CHF | −2.47% | 4 | 0.06 | 22.01 | 1.82 CHF | +1.10% | 2.23% | 매수 |
 GALDGalderma Group AG | 45.37 B CHF | 189.334 CHF | −3.60% | 213 | 0.88 | 65.20 | 2.90 CHF | +110.71% | 0.18% | 매수 |
| GALDGalderma Group AG | 45.37 B CHF | 191.75 CHF | −1.74% | 580.42 K | 1.03 | 66.03 | 2.90 CHF | +110.71% | 0.18% | 매수 |
 LONNLonza Group AG | 45.09 B CHF | 663.4 CHF | −1.34% | 212.06 K | 1.42 | — | −1.55 CHF | −115.18% | 0.76% | 매수 |
| LO3Lonza Group AG | 45.09 B CHF | 658.428 CHF | −2.15% | 34 | 0.12 | — | −1.55 CHF | −115.18% | 0.76% | 매수 |
 IX1IDEXX Laboratories, Inc. | 44.99 B CHF | 561.726 CHF | +28.10% | 100 | 4.37 | 45.29 | 12.40 CHF | +23.43% | 0.00% | 매수 |
 D8YSandoz Group Ltd | 36.14 B CHF | 83.263 CHF | +0.29% | 1.07 K | 1.70 | 70.72 | 1.18 CHF | +166.48% | 0.97% | 중립 |
| SDZSandoz Group Ltd | 36.14 B CHF | 83.78 CHF | +0.19% | 893 K | 0.61 | 71.16 | 1.18 CHF | +166.48% | 0.97% | 중립 |
 RVMDRevolution Medicines, Inc. | 34.99 B CHF | 150.462 CHF | −4.57% | 59 | 0.85 | — | −7.13 CHF | −99.36% | 0.00% | 강력 매수 |
 ALCAlcon AG | 31.62 B CHF | 61.30 CHF | −2.36% | 1.23 M | 1.27 | 59.12 | 1.04 CHF | −44.92% | 0.44% | 매수 |
| 2U3Alcon AG | 31.62 B CHF | 60.879 CHF | −3.84% | 1.21 K | 1.58 | 58.72 | 1.04 CHF | −44.92% | 0.44% | 매수 |
 ZOEZoetis, Inc. Class A | 30.13 B CHF | 65.569 CHF | +0.36% | 10 | 0.21 | 13.34 | 4.91 CHF | +6.56% | 2.38% | 중립 |
 DC4DexCom, Inc. | 26.97 B CHF | 64.471 CHF | −10.31% | 936 | 7.81 | 30.23 | 2.13 CHF | +49.03% | 0.00% | 강력 매수 |
 IM8NInsmed Incorporated | 19.73 B CHF | 91.668 CHF | −4.48% | 48 | — | — | −2.35 CHF | +52.19% | 0.00% | 강력 매수 |
 22UABioNTech SE Sponsored ADRDR | 18.62 B CHF | 70.648 CHF | −5.05% | 33 | 0.78 | — | −6.34 CHF | −399.64% | 0.00% | 매수 |
 VTRSViatris, Inc. | 18.04 B CHF | 15.755 CHF | +4.80% | 74 | 1.31 | — | −0.29 CHF | +87.49% | 2.50% | 매수 |
 DULAlnylam Pharmaceuticals, Inc | 17.64 B CHF | 138.579 CHF | −27.27% | 100 | 1.99 | 8.37 | 16.55 CHF | +8,543.33% | 0.00% | 매수 |
 ZBHZimmer Biomet Holdings, Inc. | 17.17 B CHF | 76.0 CHF | +1.33% | 34 | 0.40 | 23.03 | 3.30 CHF | +2.53% | 0.87% | 중립 |
 STMNStraumann Holding AG | 17.12 B CHF | 104.50 CHF | −1.28% | 363.31 K | 0.79 | 45.17 | 2.31 CHF | −5.94% | 0.93% | 매수 |
| QS51Straumann Holding AG | 17.12 B CHF | 106.125 CHF | −0.81% | 103 | 0.69 | 45.87 | 2.31 CHF | −5.94% | 0.93% | 매수 |
 PHBNSonova Holding AG | 16.68 B CHF | 287.176 CHF | −1.86% | 128 | 0.34 | 39.77 | 7.22 CHF | −20.12% | 1.62% | 중립 |
| SOONSonova Holding AG | 16.68 B CHF | 288.0 CHF | −1.44% | 197.29 K | 1.42 | 39.88 | 7.22 CHF | −20.12% | 1.62% | 중립 |
 EX9Exelixis, Inc. | 14.51 B CHF | 53.452 CHF | +0.45% | 400 | 1.21 | 19.14 | 2.79 CHF | +47.64% | 0.00% | 매수 |
 CBHDColoplast A/S Class B | 14.4 B CHF | 59.193 CHF | +1.18% | 2 K | 11.23 | 34.34 | 1.72 CHF | −14.44% | 4.40% | 중립 |
 WDH1Demant A/S | 9.42 B CHF | 45.623 CHF | +35.57% | 7 K | 40.70 | 48.03 | 0.95 CHF | −29.67% | 0.00% | 매수 |
 QGENQIAGEN NV | 8.58 B CHF | 41.772 CHF | +40.91% | 10 | 0.10 | 26.25 | 1.59 CHF | +11.53% | 0.69% | 중립 |
 YDO1Madrigal Pharmaceuticals, Inc. | 7.6 B CHF | 358.641 CHF | −0.42% | 12 | 0.38 | — | −5.00 CHF | +51.78% | 0.00% | 강력 매수 |
 HDP1Arrowhead Pharmaceuticals, Inc. | 7.12 B CHF | 50.112 CHF | −7.82% | 2 K | 17.39 | — | −1.81 CHF | −80.90% | 0.00% | 강력 매수 |
 BANBBachem Holding AG Class B | 6.12 B CHF | 79.70 CHF | −0.06% | 58.18 K | 0.78 | 40.10 | 1.99 CHF | +11.05% | 1.10% | 매수 |
| BANBBachem Holding AG Class B | 6.12 B CHF | 78.273 CHF | −3.74% | 12 | 0.15 | 39.38 | 1.99 CHF | +11.05% | 1.10% | 매수 |
 YPSNYpsomed Holding AG | 5.28 B CHF | 394.4 CHF | −0.05% | 8.88 K | 0.79 | 24.20 | 16.30 CHF | +154.29% | 1.10% | 매수 |
| OWXYpsomed Holding AG | 5.28 B CHF | 387.308 CHF | −4.22% | 1 | 0.04 | 23.76 | 16.30 CHF | +154.29% | 1.10% | 매수 |
 1CGCRISPR Therapeutics AG | 4.11 B CHF | 40.056 CHF | −2.75% | 600 | 1.15 | — | −3.97 CHF | +10.71% | 0.00% | 매수 |
 SFZNSiegfried Holding AG | 3.38 B CHF | 71.467 CHF | −3.66% | 32 | 0.16 | 18.28 | 3.91 CHF | +11.09% | 0.53% | 매수 |
| SFZNSiegfried Holding AG | 3.38 B CHF | 72.00 CHF | −1.37% | 104.69 K | 0.94 | 18.41 | 3.91 CHF | +11.09% | 0.53% | 매수 |
 IOVAIovance Biotherapeutics Inc | 3.22 B CHF | 7.100 CHF | −40.91% | 300 | — | — | −0.58 CHF | +40.09% | 0.00% | 매수 |
 FIEFielmann Group AG | 3.19 B CHF | 36.668 CHF | +1.13% | 1 K | 6.49 | 15.75 | 2.33 CHF | +23.36% | 3.38% | 매수 |
 TECNTecan Group AG | 3.14 B CHF | 257.6 CHF | −1.68% | 75.47 K | 0.91 | — | −9.16 CHF | −284.91% | 1.23% | 매수 |
| TENTecan Group AG | 3.14 B CHF | 253.933 CHF | −4.60% | 56 | 1.10 | — | −9.16 CHF | −284.91% | 1.23% | 매수 |
 AFXCarl Zeiss Meditec AG | 2.94 B CHF | 32.719 CHF | +1.21% | 100 | 0.21 | 32.70 | 1.00 CHF | −41.01% | 1.54% | 매도 |
 6MDMedacta Group SA | 2.48 B CHF | 106.788 CHF | −10.36% | 170 | 1.81 | 29.85 | 3.58 CHF | −20.27% | 0.89% | 매수 |
| MOVEMedacta Group SA | 2.48 B CHF | 106.4 CHF | −13.64% | 142.07 K | 4.92 | 29.74 | 3.58 CHF | −20.27% | 0.89% | 매수 |
 COTNCOMET Holding AG | 2.48 B CHF | 298.0 CHF | −0.13% | 57.39 K | 1.51 | 129.88 | 2.29 CHF | −54.20% | 0.16% | 강력 매수 |
| EZP1COMET Holding AG | 2.48 B CHF | 304.344 CHF | +2.26% | 4 | 0.08 | 132.65 | 2.29 CHF | −54.20% | 0.16% | 강력 매수 |
 RXRXRecursion Pharmaceuticals, Inc. Class A | 1.98 B CHF | 3.117 CHF | −4.45% | 4 K | 5.28 | — | −0.75 CHF | +48.25% | 0.00% | 매수 |
 NDH1Metall Zug AG Class B | 1.8 B CHF | 820.202 CHF | −0.27% | 2 | 0.21 | — | −12.44 CHF | +56.17% | 0.00% | 중립 |
| METNMetall Zug AG Class B | 1.8 B CHF | 835 CHF | 0.00% | 228 | 2.26 | — | −12.44 CHF | +56.17% | 0.00% | 중립 |
 SKANSKAN Group AG | 1.61 B CHF | 69.7 CHF | −0.99% | 33.43 K | 0.94 | 52.26 | 1.33 CHF | +85.35% | 0.31% | 강력 매수 |
| 7VGSKAN Group AG | 1.61 B CHF | 73.514 CHF | +1.51% | 41 | 0.40 | 55.12 | 1.33 CHF | +85.35% | 0.31% | 강력 매수 |
 MEDMedartis Holding AG | 1.51 B CHF | 109.6 CHF | +2.05% | 14.27 K | 0.78 | 91.44 | 1.20 CHF | — | 0.00% | 강력 매수 |
 NVV1Novavax, Inc. | 1.44 B CHF | 8.008 CHF | −3.65% | 500 | 1.61 | — | −1.23 CHF | −168.74% | 0.00% | 매수 |
 8H0PolyPeptide Group AG | 1.36 B CHF | 43.866 CHF | −0.37% | 400 | 0.36 | 108.53 | 0.40 CHF | — | 0.00% | 중립 |
| PPGNPolyPeptide Group AG | 1.36 B CHF | 40.05 CHF | −1.11% | 21.45 K | 0.97 | 99.08 | 0.40 CHF | — | 0.00% | 중립 |
| PPPGNEPolyPeptide Group AG TEMP | 1.36 B CHF | 44.00 CHF | +0.34% | 1.97 K | 0.19 | 108.86 | 0.40 CHF | — | 0.00% | 등급 없음 |
 IDIAIdorsia Ltd. | 1.19 B CHF | 4.058 CHF | −3.38% | 997.2 K | 1.24 | — | −1.11 CHF | −66.32% | 0.00% | 중립 |
| 19TIdorsia Ltd. | 1.19 B CHF | 4.023 CHF | −8.69% | 100 | 0.08 | — | −1.11 CHF | −66.32% | 0.00% | 중립 |